Elon Musk Acknowledges Therapeutic Potential Of Psychedelic Drugs: Will This Impact The Markets?

Elon Musk expressed his support for the therapeutic potential of psychedelic drugs.

The Space X and Tesla TSLA CEO shared his opinion on psychedelic substances in a Q&A at the CodeCon event on Tuesday.

“I think generally people should be open to psychedelics,” said Musk after being asked his opinion by Ronan Levy, executive chairman of Field Trip Health FTRP FTRP, which is one of the companies taking psychedelic substances to legality in what has become known as the “psychedelic renaissance.”

In recent years, a number of companies went public with plans to advance psychedelics such as LSD, ayahuasca and psilocybin mushrooms through FDA approval for the treatment of several mental health conditions and other indications.

“You’ve spent a lot of time talking about outer space, and I want to ask you about inner space. What role do you think psychedelics may have in addressing some of the more destructive tendencies of humanity?” Levy asked Musk.

“A lot of people making laws are kind of from a different era,” Musk replied. “As the new generation gets into political power, I think we will see greater receptivity to the benefits of psychedelics.”

Benzinga’s Take: In recent years, Elon Musk’s opinions have proven to have an overwhelmingly strong influence on the markets.

Earlier this year, the billionaire entrepreneur’s influence on the crypto markets was made apparent when he single-handedly affected the prices of cryptocurrencies like Bitcoin BTC/USD and Dogecoin DOGE/USD.

As the market for psychedelic medicines grows larger, comments from highly influential figures like Musk could have a strong impact on the industry’s ability to raise capital, which is largely derived from the public’s opinion and support for the sector.

Photo: Daniel Oberhaus at Wikimedia Commons.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisPenny StocksMarketsElon MuskPsychedelics
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.